The most painful point of SME or Spin-offs, is actually the blood – fund / finance. Indes CN has been rooted in Innovation Industry for years, built-up the trustful partnership especially in capital specialized in overseas innovation investment, including pre-seed / seed / angel rounds. Those capital are featured on aiming for long-term, and willing to grow up with the invested companies. Focus mainly on medical / human care innovation would be preferred.

To learn more, pls contact.